InspireMD, Inc.
(NYSE Amex Equities : NSPR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.20%59.700.8%$473.50m
MDTMedtronic PLC
0.00%80.410.6%$451.00m
ALGNAlign Technology, Inc.
2.08%265.076.3%$397.96m
ISRGIntuitive Surgical, Inc.
1.84%427.512.5%$385.08m
TMOThermo Fisher Scientific Inc.
1.23%211.711.0%$340.74m
BDXBecton, Dickinson and Company
0.91%220.311.1%$331.59m
BAXBaxter International Inc.
1.39%68.371.7%$252.42m
SYKStryker Corporation
1.72%161.701.3%$248.56m
BSXBoston Scientific Corporation
2.72%27.201.1%$232.35m
EWEdwards Lifesciences Corporation
1.47%135.641.2%$199.00m
ZBHZimmer Biomet Holdings, Inc.
1.10%118.871.7%$170.47m
ABMDABIOMED, Inc.
1.70%268.453.3%$141.47m
IDXXIDEXX Laboratories, Inc.
2.04%187.613.7%$126.24m
VARVarian Medical Systems, Inc.
1.12%121.189.1%$125.60m
XRAYDENTSPLY International Inc.
0.98%57.673.0%$117.48m

Company Profile

InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.